Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, innovative and quantitative technology for the follow-up of neuronal lesions by cerebral imaging: the Quantitative Susceptibility Mapping (QSM) technology. Ventio, with the QSM technology, is alongside … Read More
BAOBAB : Building large instruments for neuroimaging: from population imaging to ultra-high magnetic fields
Indeed, the company has been hosted by Marseille Innovation for one year and has benefited from the support of the Regional Institute of Business Leaders (IRCE), and thus from the advice of these networks of experts on the critical issues … Read More
Ventio is proud to welcome Miguel Guevara in the QSM4SENIOR project! Miguel joined the project-team QSM4SENIOR at the beginning of April as a specialist researcher. A strategic recruitment to support this EOSC-Life-funded project on which Ventio is a partner with … Read More
QSM4SENIOR: the gold standard for rusting brains Ventio and NeuroSpin are partners in a recently-selected project by the European Open Science Cloud in Life Sciences (EOSC-Life) to reveal an innovative early biomarker of pathological aging brain. Ventio engages in research … Read More